MARC Record from marc_columbia

LEADER: 02226pam a22004934a 4500
001 6099810
005 20221121234714.0
008 060321t20072007flua b 001 0 eng
010 $a 2006008937
015 $aGBA654241$2bnb
016 7 $a101272061$2DNLM
016 7 $a013490310$2Uk
020 $a0849392195 (alk. paper)
020 $a9780849392191 (alk. paper)
020 $a1420008900
020 $a9781420008906
020 $z9780849392191 (hardcover : alk. paper)
020 $z9781420008906
029 1 $aNLM$b101272061
029 1 $aYDXCP$b2414335
035 $a(OCoLC)ocm65195317
035 $a(OCoLC)65195317
035 $a(NNC)6099810
035 $a6099810
040 $aDNLM/DLC$cDLC$dYDX$dNLM$dBAKER$dUKM$dBTCTA$dYDXCP$dOrLoB-B
042 $apcc
050 00 $aRS431.A64$bT48 2007
060 00 $a2007 A-502
060 10 $aQV 269$bT544p 2007
082 00 $a616.99/4061$222
100 1 $aThurston, David E.$0http://id.loc.gov/authorities/names/n2006181051
245 10 $aChemistry and pharmacology of anticancer drugs /$cDavid E. Thurston.
260 $aBoca Raton :$bCRC Press/Taylor & Francis,$c[2007], ©2007.
300 $a290 pages :$billustrations ;$c25 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $gCh. 1.$tIntroduction to cancer -- $gCh. 2.$tAntimetabolites -- $gCh. 3.$tDNA-interactive agents -- $gCh. 4.$tAntitubulin agents -- $gCh. 5.$tMolecularly targeted agents -- $gCh. 6.$tHormonal therapies -- $gCh. 7.$tTumor-targeting strategies -- $gCh. 8.$tBiological agents -- $gCh. 9.$tThe future -- $gCh. 10.$tPersonalized treatments -- $gCh. 11.$tAdjunct therapies.
650 0 $aAntineoplastic agents.$0http://id.loc.gov/authorities/subjects/sh85005714
650 12 $aAntineoplastic Agents$xpharmacology.$0https://id.nlm.nih.gov/mesh/D000970Q000494
650 22 $aAntineoplastic Agents$xchemistry.$0https://id.nlm.nih.gov/mesh/D000970Q000737
856 41 $3Table of contents only$uhttp://www.loc.gov/catdir/toc/ecip0610/2006008937.html
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/enhancements/fy0654/2006008937-d.html
852 00 $boff,hsl$hRS431.A64$iT48 2007